项目编号：DT-BD-20200412-008
Project Number: DT-BD-20200412-008
项目内容：中国大型制药企业希望收购医药制剂生产标的（降压药、支气管药物类等），有糖尿病、高血压、高血脂大类别药物的药证，有一定规模的制剂生产车间，项目团队稳定，通过一致性评价或者正在做。
Request: Large Chinese pharmaceutical companies are looking to acquire entities for the production of pharmaceuticals (hypertensive drugs, bronchial drugs, etc.). The desired companies are expected to have the drug certificates for large categories of drugs such as diabetes, hypertension, and hyperlipidemia, have a certain scale of production workshops, and the project team is stable. Have passed the BE evaluation or are working on it.
目标领域：降压药、支气管药物类等
Target area: Antihypertensive drugs, bronchial drugs, etc.
目标阶段：通过一致性评价或者正在做
Target stage: Have passed the BE evaluation or are working on it
药物类别：小分子药或者生物药均可
Drug category: small molecule drugs or biological drugs
目标权益：中国大陆
Target right: Mainland China
如果您对该合作机会感兴趣，欢迎与我们联系！我们将与您详细探讨。谢谢！
If you are interested in introducing this collaboration opportunity, please contact us. We will discuss with you in details. Thank you very much!
联系人 (Contact)：Will
电话 (Mobile)：13564569657
微信 (Wechat)：27674131
邮箱 (E-mail)：BD@drugtimes.cn
邮件主题请注明：项目编号：DT-BD-20200412-008
In the e-mail subject, please include “Project Number: DT-BD-20200412-008”
发布者：DrugTimes001，转载请首先联系contact@drugtimes.cn获得授权
为好文打赏 支持药时代 共创新未来！ 
